ARTICLE | Clinical News
Amgen regulatory update
October 4, 1993 7:00 AM UTC
Amgen Inc. (AMGN) Roche Holdings AG said the European Community's Committee for Proprietary Medicinal Products unanimously recommended Neupogen/Granulokine recombinant granulocyte-colony stimulating...